Skip to menu Skip to content Skip to footer
Professor David Mudge
Professor

David Mudge

Email: 

Overview

Background

My current appointment is Director of Kidney Services at Redland Hospitals in Metro South, Brisbane, where I practice as a senior consultant nephrologist.

My research interests are varied and include post-transplant anaemia and iron metabolism, and novel measures of iron status such as hepcidin; improving dialysis outcomes though the implementation of evidence-based guidelines; kidney disease due to thrombotic microangiopathy (particularly aHUS) and the role of inhibitors of the complement system in kidney disease; and the use of honey to prevent infections in dialysis patients.

I am committed to teaching medical students and young nephrologists, and am actively involved in medical education at all levels.

Availability

Professor David Mudge is:
Available for supervision
Media expert

Fields of research

Qualifications

  • Bachelor of Medicine, of Surgery and of Obstetrics, The University of Queensland
  • Doctoral (Research) of Medicine, The University of Queensland

Research impacts

The impact of my research in peritoneal dialysis has been a significant improvement in PD-related infection rates in Australia, which until a few years ago were worse than many other countries in the world. Through a variety of initiatives including a project aiming to improve the use of evidence-based guidelines in clinical practice, we have seen a significant improvement in PD-related infections (particularly peritonitis but also exit-site infections), one of the most significant contributors to peritoneal dialysis technique failure.

In kidney transplantation my research has helped to clarify the role of immune suppressing medications on iron availability and anaemia and has looked at novel ways of measuring iron status in patients with kidney disease as well as better ways of enhancing iron stores in these patients.

Works

Search Professor David Mudge’s works on UQ eSpace

145 works between 2000 and 2024

121 - 140 of 145 works

2006

Conference Publication

Effectiveness of a cardiovascular risk factor modification program in insulin-resistant renal transplant recipients

Armstrong, K., Johnson, D., De Silva, N., Pidcock, R., Orazio, L., Prins, J., Campbell, S., Hawley, C., Mudge, D., Marwick, T. and Isbel, N. (2006). Effectiveness of a cardiovascular risk factor modification program in insulin-resistant renal transplant recipients. 24th Annual Scientific Meeting of the Transplantation Society of Australia and New Zealand, The Australian Academy of Science Canberra, ACT, Australia, 29–31 March 2006. Basingstoke, U. K.: Transplantation Society of Australia and New Zealand. doi: 10.1111/j.1440-1711.2006.01450.x

Effectiveness of a cardiovascular risk factor modification program in insulin-resistant renal transplant recipients

2006

Conference Publication

Outcomes of kidney transplant recipients on Warfarin at time of transplant

Wong, J. S., Campbell, S. B., Hawley, C. M., Johnson, D. W., Mudge, D. W. and Isbel, N. M. (2006). Outcomes of kidney transplant recipients on Warfarin at time of transplant. 42nd Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourne, Australia, 14–18 August 2006. Hoboken, NJ United States: Wiley-Blackwell.

Outcomes of kidney transplant recipients on Warfarin at time of transplant

2006

Conference Publication

Estimated donor GFR is the most important donor characteristic predicting graft function in recipients of live donor kidneys

Mudge, D. W., Hawley, C. M., Johnson, D., Isbel, N. M., Campbell, S. B., Griffin, A., Preston, J. and Nicol, D. (2006). Estimated donor GFR is the most important donor characteristic predicting graft function in recipients of live donor kidneys. 42nd Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourne, Australia, 14–18 August 2006. Hoboken, NJ United States: Wiley-Blackwell.

Estimated donor GFR is the most important donor characteristic predicting graft function in recipients of live donor kidneys

2006

Journal Article

Estimated donor glomerular filtration rate is the most important donor characteristic predicting graft function in recipients of kidneys from live donors

Hawley, Carmel M., Kearsley, Jamie, Campbell, Scott B., Mudge, David, Isbel, Nicole M., Johnson, David W., May, Kylie, Preston, John, Griffin, Anthony, Wall, Daryl, Burke, John, McTaggart, Steven J., Frohloff, Gayle and Nicol, David (2006). Estimated donor glomerular filtration rate is the most important donor characteristic predicting graft function in recipients of kidneys from live donors. Transplant International, 20 (1), 64-72. doi: 10.1111/j.1432-2277.2006.00400.x

Estimated donor glomerular filtration rate is the most important donor characteristic predicting graft function in recipients of kidneys from live donors

2006

Journal Article

Effect of previously failed kidney transplantation on peritoneal dialysis outcomes in the Australian and New Zealand patient populations

Badve, Sunil V., Hawley, Carmel M., McDonald, Stephen P., Mudge, David W., Rosman, Johan B., Brown, Fiona G., Johnson, David W. and ANZDATA Registry PD Working Comm (2006). Effect of previously failed kidney transplantation on peritoneal dialysis outcomes in the Australian and New Zealand patient populations. Nephrology Dialysis Transplantation, 21 (3), 776-783. doi: 10.1093/ndt/gfi248

Effect of previously failed kidney transplantation on peritoneal dialysis outcomes in the Australian and New Zealand patient populations

2006

Conference Publication

Bone histology in alternate nightly home haemodialysis

van Eps, Carolyn, Jeffries, Janine, Diamond, Terrence, Anderson, John, Johnson, David, Campbell, Scott, Isbel, Nicole, Mudge, David and Hawley, Carmel (2006). Bone histology in alternate nightly home haemodialysis. 43rd ERA-EDTA Congress, Glasgow, Scotland, 15-18 July 2006 . Oxford, United Kingdom: Oxford University Press.

Bone histology in alternate nightly home haemodialysis

2006

Journal Article

Deceased donor renal transplantation - does side matter?

Johnson, David W., Mudge, David W., Kaisar, Mohammed O., Campbell, Scott B., Hawley, Carmel M., Isbel, Nicole M., Wall, Daryl, Griffin, Anthony, Preston, John and Nicol, David L. (2006). Deceased donor renal transplantation - does side matter?. Nephrology Dialysis Transplantation, 21 (9), 2583-2588. doi: 10.1093/ndt/gfl268

Deceased donor renal transplantation - does side matter?

2006

Conference Publication

A randomized, controlled trial of coiled versus straight swan neck tenckhoff catheters in peritoneal dialysis patients

Wong, J. S., Wiggins, K. J., Campbell, S. B., Isbel, N. M., Mudge, D. W., Hawley, C. M. and Johnson, D. W. (2006). A randomized, controlled trial of coiled versus straight swan neck tenckhoff catheters in peritoneal dialysis patients. 42nd Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Melbourne, Australia, 14–18 August 2006. Hoboken, NJ United States: Wiley-Blackwell.

A randomized, controlled trial of coiled versus straight swan neck tenckhoff catheters in peritoneal dialysis patients

2006

Conference Publication

Effectiveness of a cardiovascular risk factor modification program in insulin-resistant renal transplant recipients

Armstrong, K., Johnson, D., De Silva, N., Pidcock, R., Orazio, L., Prins, J., Campbell, S., Hawley, C., Mudge, D., Marwick, T. and Isbel, N. (2006). Effectiveness of a cardiovascular risk factor modification program in insulin-resistant renal transplant recipients. 24th Annual Scientific Meeting of the Transplantation Society of Australia and New Zealand, Canberra, Australia, 29–31 March 2006. Oxford, United Kingdom: John Wiley & Sons.

Effectiveness of a cardiovascular risk factor modification program in insulin-resistant renal transplant recipients

2005

Journal Article

Hepatic vein stenting for recurrent ascites in polycystic liver and kidney disease

Mudge, DW, Taylor, J and Bannister, KM (2005). Hepatic vein stenting for recurrent ascites in polycystic liver and kidney disease. Nephrology Dialysis Transplantation, 20 (11), 2566-2568. doi: 10.1093/ndt/gfi051

Hepatic vein stenting for recurrent ascites in polycystic liver and kidney disease

2005

Journal Article

Pharmacokinetics and normal scintigraphic appearance of 99mTc aprotinin

Sojan, SM, Smyth, DR, Tsopelas, C, Mudge, D, Collins, PJ and Chatterton, BE (2005). Pharmacokinetics and normal scintigraphic appearance of 99mTc aprotinin. Nuclear Medicine Communications, 26 (6), 535-539. doi: 10.1097/00006231-200506000-00009

Pharmacokinetics and normal scintigraphic appearance of 99mTc aprotinin

2005

Journal Article

Obliterative bronchiotitis or opportunistic infection? A diagnostic challenge in a renal transplant patient (Letter to the Editor)

Mudge, David W., Johnson, David W., Isbel, Nicole M., Campbell, Scott B., Nicol, David L. and Hawley, Carmel M. (2005). Obliterative bronchiotitis or opportunistic infection? A diagnostic challenge in a renal transplant patient (Letter to the Editor). Nephrology Dialysis Transplantation, 20 (1), 246-247. doi: 10.1093/ndt/gfh580

Obliterative bronchiotitis or opportunistic infection? A diagnostic challenge in a renal transplant patient (Letter to the Editor)

2005

Journal Article

Randomized, controlled trial of topical exit-site application of honey (Medihoney) versus Mupirocin for the prevention of catheter-associated infections in hemodialysis patients

Johnson, David Wayne, van Eps, Carolyn, Mudge, David William, Wiggins, Kathryn Joan, Armstrong, Kirsty, Hawley, Carmel Mary, Campbell, Scott Bryan, Isbel, Nicole Maree, Nimmo, Graeme Robert and Gibbs, Harry (2005). Randomized, controlled trial of topical exit-site application of honey (Medihoney) versus Mupirocin for the prevention of catheter-associated infections in hemodialysis patients. Journal of The American Society of Nephrology, 16 (5), 1456-1462. doi: 10.1681/ASN.2004110997

Randomized, controlled trial of topical exit-site application of honey (Medihoney) versus Mupirocin for the prevention of catheter-associated infections in hemodialysis patients

2005

Journal Article

Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant

Atcheson, Bronwyn A., Taylor, Paul J., Mudge, David W., Johnson, David W., Hawley, Carmel M., Campbell, Scott B., Isbel, Nicole M., Pillans, Peter I. and Tett, Susan E. (2005). Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant. British Journal of Clinical Pharmacology, 59 (3), 271-280. doi: 10.1111/j.1365-2125.2004.02235.x

Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant

2005

Journal Article

Randomized trial of FX high flux vs standard high flux dialysis for homocysteine clearance

Mudge, David W., Rogers, Robyn, Hollett, Peter, Law, Belinda, Reiger, Kylie, Petrie, James J. B., Price, Lee, Johnson, David W., Campbell, Scott B., Isbel, Nicole M., Sullivan, Matthew and Hawley, Carmel M. (2005). Randomized trial of FX high flux vs standard high flux dialysis for homocysteine clearance. Nephrology Dialysis Transplantation, 20 (10), 2178-2185. doi: 10.1093/ndt/gfh987

Randomized trial of FX high flux vs standard high flux dialysis for homocysteine clearance

2004

Journal Article

Response: Iron Therapy in Renal Transplant Recipients

Johnson, David W., Mudge, David W., Atcheson, Bronwyn, Taylor, Paul J., Sturtevant, Joanna M., Hawley, Carmel M., Campbell, Scott B., Isbel, Nicole M., Nicol, David L. and Pillans, Peter (2004). Response: Iron Therapy in Renal Transplant Recipients. Transplantation, 78 (8), 1240-1240. doi: 10.1097/01.TP.0000137102.92992.5F

Response: Iron Therapy in Renal Transplant Recipients

2004

Journal Article

Coca-Cola and kangaroos (Case report)

Mudge, David W. and Johnson, David W. (2004). Coca-Cola and kangaroos (Case report). Lancet, 364 (9440), 1190-1190. doi: 10.1016/S0140-6736(04)17111-0

Coca-Cola and kangaroos (Case report)

2004

Journal Article

Severe Toxicity Associated with a Markedly Elevated Mycophenolic Acid Free Fraction in a Renal Transplant Recipient

Mudge, David, Atcheson, Bronwyn, Taylor, Paul, Pillans, Peter and Johnson, David (2004). Severe Toxicity Associated with a Markedly Elevated Mycophenolic Acid Free Fraction in a Renal Transplant Recipient. Therapeutic Drug Monitoring, 26 (4), 453-455. doi: 10.1097/00007691-200408000-00017

Severe Toxicity Associated with a Markedly Elevated Mycophenolic Acid Free Fraction in a Renal Transplant Recipient

2004

Journal Article

Free mycophenolic acid should be monitored in renal transplant recipients with hypoalbuminemia

Atcheson, Bronwyn A., Taylor, Paul J., Kirkpatrick, Carl M. J., Duffull, Stephen B., Mudge, David W., Pillans, Peter I., Johnson, David W. and Tett, Susan E. (2004). Free mycophenolic acid should be monitored in renal transplant recipients with hypoalbuminemia. Therapeutic Drug Monitoring, 26 (3), 284-286. doi: 10.1097/00007691-200406000-00011

Free mycophenolic acid should be monitored in renal transplant recipients with hypoalbuminemia

2004

Journal Article

The effect of oral iron administration on mycophenolate mofetil absorption in renal transplant recipients: a randomized, controlled trial

Mudge, David W., Taylor, Paul J., Atcheson, Bronwyn A., Sturtevant, Joanna M., Hawley, Carmel M., Campbell, Scott B., Isbel, Nicole M., Nicol, David L., Pillans, Peter I. and Johnson, David W. (2004). The effect of oral iron administration on mycophenolate mofetil absorption in renal transplant recipients: a randomized, controlled trial. Transplantation, 77 (2), 206-209. doi: 10.1097/01.TP.0000100446.44001.00

The effect of oral iron administration on mycophenolate mofetil absorption in renal transplant recipients: a randomized, controlled trial

Funding

Past funding

  • 2019 - 2021
    A Targeted Education ApproaCH to improve Peritoneal Dialysis outcomes - Cluster Randomised Controlled Trial (MSH Research Support Scheme Project Grant administered by MSHHS)
    Metro South Hospital and Health Service
    Open grant

Supervision

Availability

Professor David Mudge is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Media

Enquiries

Contact Professor David Mudge directly for media enquiries about:

  • Anaemia
  • Chronic kidney disease
  • Iron regulation
  • Kidney disease
  • Kidney transplantation
  • Organ transplant - kidney
  • Transplant - kidney

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au